Select Page

31st Annual Perspectives in Urology: Point Counterpoint

Westin Kierland Resort, Scottsdale, Arizona
October 18-20, 2024

innovations in urologic practice logo

Overview

The 31st Annual Perspectives in Urology: Point Counterpoint will bring together leading experts in urology, medical oncology, and radiation oncology to discuss and debate the latest topics in men’s health, general urology, and genitourinary cancers. This annual interactive conference will offer topical lectures, pro/con debates, and interactive panel discussions. Topics include LUTS, localized and advanced prostate cancer, bladder cancer and immunotherapy, upper tract cancer management, renal cell carcinoma, MRI and imaging, and other urologic topics.

The goal of PCP 31 is to address key questions on practice-changing developments in these topics, and to examine the next generation in diagnosis and treatment. The conference’s format includes not only didactic lectures, but also debates, point-counterpoint discussion panels.

Co-Program Director

E. David Crawford, MD

E. David Crawford, MD

 Professor of Urology
University of California,
San Diego
La Jolla, California

Co-Program Director

Benjamin R. Lee, MD

Benjamin R. Lee, MD

The George W. Drach, MD Endowed Chair and Professor
Department of Urology
University of Arizona College of Medicine
Director, GU Cancer & Disease Oriented Strategic Planning Team
University of Arizona Cancer Center
Tucson, Arizona

Agenda

The 31st Annual Perspectives in Urology: Point Counterpoint (PCP 31) conference offers a robust program with multi-track sessions, debates, discussion panels, and more. Join us October 18-20, 2024, in Scottsdale, Arizona.

This is a working agenda and subject to change. Please check back often for the latest updates.

Note: All industry activities will be held in a separate room.

TimeCourse TitleSpeaker(s)
Friday, October 18, 2024 (All Times Mountain Standard Time)
7:00am–5:00pmRegistration and Check-In
12:40pm-1:30PMIndustry-supported Lunch programModerator: Mary-Ellen Taplin, MD
1:30pm-1:50pmBreak and Visit Exhibits
1:50pm–4:15pmSPCS/PCP Joint Session: Advances in Metastatic DiseaseModerator: Mary-Ellen Taplin, MD
1:50pm–2:10pmTreatment of Oligometastatic DiseaseMary-Ellen Taplin, MD
2:10pm–2:30pmHormone-sensitive Metastatic Disease: 1, 2 or 3 Drugs?Alan H. Bryce, MD
2:30pm–2:50pmOptimal Management of Biochemical RecurrenceMary-Ellen Taplin, MD
2:50pm–3:10pmCardiovascular Side Effects of New Hormone TherapiesWilliam K. Oh, MD
3:10pm–3:30pmNovel Targeted Treatments for Metastatic DiseaseAlan H. Bryce, MD
3:30pm–3:40pmBreak & Visit Exhibits
3:40pm–4:00pmTreating Neuroendocrine Prostate CancerWilliam K.Oh, MD
4:00pm-4:15pmPanel Discussion
4:15pm-6:00pmSession 8: Epidemiology and Early DetectionModerator: Sigrid V. Carlsson, MD, PhD, MPH
4:15pm-4:35pmScreening Guidelines for Prostate Cancer: Do We Have Consensus?Sigrid V. Carlsson, MD, PhD, MPH
4:35pm-4:55pmUpdate on New Biomarkers for Prostate CancerE. David Crawford, MD
4:55pm-5:15pmProstate MRI as a Screening and Surveillance ToolAlberto Vargas, MD
5:15pm-5:35pmPSMA-targeted PET in the Diagnosis and Staging of Prostate CancerMichael A. Gorin, MD
5:35pm–6:00pmPanel Discussion
6:00pm-7:00pmPCP Welcome Reception
Saturday, October 19, 2024 (All Times Mountain Standard Time)
6:30am–5:00pmRegistration and Open
12:00pm-5:30pmExhibits Open
12:00pm–1:00pmIndustry Supported Lunch Symposium
1:00pm–1:15pmWelcome and IntroductionsE. David Crawford, MD, and Benjamin R. Lee, MD, MBA
1:15pm - 3:35pmSession 3: Andrology, Hypogonadism, Men’s HealthMitchell R. Humphreys, MD, MPH, and Faysal A. Yafi, MD
1:15pm–1:35pmTestosterone Deficiency: Workup and ManagementPriyanka Bearelly, MD
1:35pm–1:55pmPoint: Surgical Correction of Peyronie’s Disease, Penile PlicationPriyanka Bearelly, MD
1:55pm–2:15pmCounterpoint: Intralesional Injection TherapyFaysal A. Yafi, MD
2:15pm–2:30pmPanel Discussion: Testosterone Replacement: Options and Patient CompliancePriyanka Bearelly, MD, and Faysal A. Yafi, MD
2:30pm–2:45pmBreak & Visit Exhibits
2:45pm–2:55pmBPH Therapies: OptilumeSunchin Kim, MD
2:55pm–3:05pmBPH Therapies: HOLEPMitchell R. Humphreys, MD, MPH
3:05pm–3:25pmMIST Procedures and Sexual DysfunctionFaysal A. Yafi, MD
3:25pm–3:35pmPanel DiscussionMitchell R. Humphreys, MD, MPH; Sunchin Kim, MD; Faysal A. Yafi, MD
3:35pm–3:50pmBreak & Visit Exhibits
3:50pm–5:20pmSession 4: Urologic OncologyBenjamin R. Lee, MD, MBA, and Juan J. Chipollini, MD
3:50pm–4:00pmPoint: Bladder Sparing Approach for Muscle Invasive Bladder Cancer (A 62 y/o man who wants bladder sparing procedure but has muscle invasion)Parminder Singh, MD
4:00pm–4:10pmCounterpoint: Radical Cystectomy for Muscle Invasive Bladder Cancer (A 62 y/o man who wants bladder sparing procedure but has muscle invasion)Juan J. Chipollini, MD
4:10pm–4:30pmManagement of High-Risk Renal Cell Carcinoma: Update 2024Benjamin R. Lee, MD, MBA
4:20pm–4:30pmPoint: Surgery for Oligometastatic Prostate CancerJuan J. Chipollini, MD
4:30pm–4:40pmCounterpoint: External Beam Radiation/Systemic Therapy for Oligometastatic Prostate CancerParminder Singh, MD
4:40pm–4:50pmThe Evolving Treatment Landscape for BCG-Unresponsive NMIBCJuan J. Chipollini, MD
4:50pm-5:00pmChanging Paradigm of First line Therapy in Locally Advanced/Metastatic Bladder CancerParminder Singh, MD
5:00pm-5:30pmPanel DiscussionJuan J. Chipollini, MD
6:30pm–8:00pmFaculty Dinner
Sunday, October 20, 2024 (All Times Mountain Standard Time)
7:00am-10:30amExhibits Open
7:00am–8:00amIndustry Supported Breakfast Symposium
8:00am–9:30amSession 6: Women’s HealthChristopher E. Wolter, MD, and Christian O. Twiss, MD
8:00am–8:10amPoint: Severe Pelvic Organ Prolapse: Robotic SacroculpopexyChristian O. Twiss, MD
8:10am–8:20amCounterpoint: Robotic Uterosacral Ligament SuspensionChristopher E. Wolter, MD
8:20am–8:40amVesicovaginal Fistula: Workup and ManagementChristian O. Twiss, MD
8:30am- 8:50amPanel Discussion: Interesting Cases: Urethral Disruption, Muscle Flaps to Optimize SuccessChristian Twiss, MD, and Christopher E. Wolter, MD
8:50am–9:00amBreak & Visit Exhibits
9:00am–10:00amSession 7: EndourologyBenjamin R. Lee, MD, MBA and Helena Chang, MD
9:00am–9:20amMetabolic Workup of StonesHelena Chang, MD
9:20am–9:30amOffice-based Removal of Small Stones: Ultrasonic Propulsion & Burst Wave Lithotripsy New Technologies in Endourology - What Do We Need and WhyHelena Chang, MD
9:30am–10:00amPanel DiscussionHelena Chang, MD, and Benjamin R. Lee, MD, MBA
10:00amClosing RemarksE. David Crawford, MD, and Benjamin R. Lee, MD, MBA

Invited Faculty

E. David Crawford, MD

E. David Crawford, MD

Program Co-Chair

University of California, San Diego
La Jolla, California

Benjamin R. Lee, MD, MBA

Benjamin R. Lee, MD, MBA

Co-Program Director

University of Arizona
Tucson, Arizona

Priyanka Bearelly, MD

Priyanka Bearelly, MD

University of Arizona
Tucson, Arizona

Alan H. Bryce, MD

Alan H. Bryce, MD

City of Hope
Phoenix, Arizona

Sigrid V. Carlsson, MD, PhD, MPH

Sigrid V. Carlsson, MD, PhD, MPH

Memorial Sloan-Kettering Cancer Center
New York, New York

Helena Chang, MD

Helena Chang, MD

Santa Clara Homestead Medical Center
Santa Clara, California

Juan J. Chipollini, MD

Juan J. Chipollini, MD

University of Arizona
Tucson, Arizona

Michael A. Gorin, MD

Michael A. Gorin, MD

Icahn School of Medicine at Mount Sinai
New York, New York

Mitchell D. Humphreys, MD, MPH

Mitchell D. Humphreys, MD, MPH

Mayo Clinic
Phoenix, Arizona

Sunchin Kim, MD

Sunchin Kim, MD

University of Arizona
Tucson, Arizona

William K. Oh, MD

William K. Oh, MD

Icahn School of Medicine at Mount Sinai
New York, New York

Parminder Singh, MD

Parminder Singh, MD

Mayo Clinic
Phoenix, Arizona

Mary-Ellen Taplin, MD

Mary-Ellen Taplin, MD

Dana-Farber Cancer Institute
Boston, Massachusetts

Christian O. Twiss, MD, FACS

Christian O. Twiss, MD, FACS

University of Arizona
Tucson, Arizona

Christopher E. Wolter, MD

Christopher E. Wolter, MD

Mayo Clinic
Phoenix, Arizona

Alberto Vargas, MD

Alberto Vargas, MD

New York University Grossman School of Medicine
New York, New York

Faysal A. Yafi, MD, FRCSC

Faysal A. Yafi, MD, FRCSC

University of California,
Irvine Medical Center
Orange, California

Help us promote PCP 31!

We’ve built a social media toolkit to help you spread the word about the meeting to your friends and colleagues. We hope you’ll help us generate awareness because we all benefit from getting together and learning. Thanks!

Accommodations

Westin Kierland Resort

6902 East Greenway Parkway
Scottsdale, AZ 85254

Discover a vitalizing oasis at The Westin Kierland Resort & Spa in Scottsdale, Arizona. Located near versatile dining and shopping at Kierland Commons, our hotel offers a stimulating experience in the Sonoran Desert. Thrill your kids at OdySea Aquarium, featuring SeaTrek Helmet Diving and a shark tour. Challenge yourself at The Westin Kierland Golf Club, our award-winning course designed by Scottsdale architect Scott Miller. Agave, The Arizona Spa & Salon, offers rejuvenating facials, manicures, pedicures, makeup services, and scalp treatments. End your day with a personalized in-room massage or simply recharge on your soft Heavenly® Bed. Experience something new and refreshing at our resort.

CONFERENCE ATTIRE:
Attire is business casual. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activities.

ROOM RESERVATIONS:
In order to make hotel reservations for this conference, you MUST first complete a  registration for the conference using the link below:
Your registration confirmation email will contain a link to the group hotel block enabling you to make a room reservation.

ROOM RATES:
$369.00 plus taxes and fees
Room rates will be subject to a mandatory daily resort fee of $35.00 per room per night.

Reservations by attendees must be received on or before Monday, September 23, 2024. Rooms will be available on a first-come, first served basis until all rooms are reserved, which may be prior to the deadline.

A deposit equal to one night’s stay is required to hold each individual’s reservation.  Should a guest cancel a reservation, the deposit will be refunded if notice is received at least twenty-one (21) working days prior to arrival, and a cancellation number is obtained.

Transportation

GROUND TRANSPORTATION:

The Westin Kierland does not provide its own shuttle service to and from the airport. We suggest Uber and Lyft, but here are some shuttle options if you would prefer to travel that way:

For information about activities in Scottsdale, see this page from the Westin Kierland Resort: https://www.marriott.com/hotels/local-things-to-do/phxws-the-westin-kierland-resort-and-spa/

CME Information

This activity is jointly provided by Medical Education Resources and Carden Jennings Publishing Co., Ltd.

This activity is supported by an educational grant from: Endo

Target Audience

This activity has been designed to meet the educational needs of urologists, medical oncologists, residents, and other healthcare professionals involved in the care of patients in men’s health, general urology, and genitourinary cancers.

Educational Objectives

  1. Review the management and treatments for urology conditions including the treatment of pelvic organ prolapse, renal stones, SUI, vesicovaginal fistula, and urethral disruption
  2. Discuss men’s health conditions and treatments, including testosterone replacement therapy and deficiency, Peyronie’s disease, ED, and early detection of prostate cancer
  3. Assess the current state of the diagnosis and management of bladder cancer
  4. Evaluate the role of biomarkers and new technologies in screening, diagnosing, and treating prostate cancer, including emerging imaging techniques, active surveillance, and PARP inhibitors
  5. Describe the present landscape of prostate cancer management, including the perineal vs transrectal prostate biopsy debate; counseling patients with favorable-risk disease using recommendation guidelines; and the advances and controversies in imaging modalities
  6. Describe the latest data on the performance of various PET radiopharmaceuticals, including PSMA PET, and the advances and controversies in imaging modalities
  7. Analyze novel androgen pathway inhibitors, immunotherapies, radiopharmaceuticals, PARP inhibitors, radioligand therapy, the TRAVERSE trial, and treatment options for advanced prostate cancer
  8. Discuss the available treatment options for advanced renal cell carcinoma

Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Carden Jennings Publishing. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit: Medical Education Resources designates this live activity for a maximum of 9.5 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit: Medical Education Resources designates this live activity for a maximum of 9.5 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 9.5 contact hours.

Physician Assistant Credit: Medical Education Resources has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.5 AAPA Category 1 CME Credits. Physician Assistants should only claim credit commensurate with the extent of their participation.

Pharmacy Credit: Medical Education Resources designates this continuing education activity for 9.5 contact hours (0.95 CEUs) of the Accreditation Council for Pharmacy Education.

This activity is certified as Knowledge based CPE.

Registration

By registering for this conference, you agree to our standard Conference Registration and Attendance Terms and Conditions agreement, which is available online at: Conference Registration and Attendance Terms and Conditions.

Support Opportunities

To inquire about support opportunities, please contact:

Denise Castetter, Senior Director of Corporate Relations
Cell: 973-769-1020
Cell: 973-769-1020  • dcastetter@cjp.com

Exhibit and Sponsor Prospectus

Meeting organized by Grand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd.

Jointly provided by Medical Education Resources and
Carden Jennings Publishing Co., Ltd.

View content from previous Perspectives in Urology: Point Counterpoint meetings